Scott Bratman

Mimecast Zendesk Amazon AWS Webflow Google Tag Manager Google Analytics Mobile Friendly Google Font API Remote

biotechnology research clinical validation molecular residual disease mrd testing cancer detection blood tests tissue-agnostic assay multiple cancer types biomarker discovery genome-wide methylome cell-free dna cfdna early detection recurrence monitoring prognostic capabilities precision medicine liquid biopsy adjuvant treatment guidance minimal residual disease cancer management multi-cancer early detection cancer care continuum high-affinity enrichment differentially-methylated regions biopharmaceutical applications plasma samples tumor tissue accessibility high-sensitivity detection surveillance testing oncology diagnostics cancer signal detection patient treatment decision-making high-throughput sequencing baseline monitoring clinical applications genomic information capture epigenetic analysis research use only assay molecular diagnostics treatment monitoring personalized medicine biological insights longitudinal tracking cancer recurrence prediction plasma-derived biomarkers surgical outcomes monitoring hpv status correlation treatment response measurement